Medicine composition for treating gynecologic postoperative low fever

A composition and technology for hypothermia, applied in the field of medicine, can solve the problems of large side effects, lack of hypothermia after obstetrics and gynecology, high cost, improve physical fitness and quality of life, optimize physical fitness and quality of life, shorten the The effect of recovery time

Inactive Publication Date: 2016-11-16
杜娟
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, western medicine mostly uses intravenous antibiotics, which is costly and has serious side effects. There is still a lack of dru...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] A pharmaceutical composition for treating postoperative hypothermia in obstetrics and gynecology. The raw material composition and parts by weight of the pharmaceutical composition are: 2 parts of cloves, 2 parts of Shichangpu, 2 parts of black fungus, and 2 parts of Codonopsis pilosula , 4 parts of Luo Han Guo, 4 parts of Moutan Cortex, 4 parts of White Horsetail, 4 parts of Cimicifuga, 6 parts of Miltonia, 6 parts of Ligustrum lucidum, 6 parts of Forsythia, 6 parts of Chonglou, 6 parts of Gentleman, 6 parts of Artemisia annua 6 parts of motherwort, 8 parts of kudzu root, 8 parts of white peony root, 8 parts of yam, 8 parts of white fresh skin, 8 parts of Andrographis paniculata, 8 parts of honeysuckle, 8 parts of hawthorn, 10 parts of cassia twig, 10 parts of ground walnut, 10 parts of Poria cocos , 10 parts of inverted root, 10 parts of Gentiana, 10 parts of black plum, 10 parts of schisandra, 10 parts of Chuanxiong, 12 parts of thistle, 12 parts of black beans, 12 pa...

Embodiment 2

[0023] A pharmaceutical composition for treating postoperative hypothermia in obstetrics and gynecology. The raw material composition and parts by weight of the pharmaceutical composition are as follows: 10 parts of cloves, 10 parts of Shichangpu, 10 parts of black fungus, and 10 parts of Codonopsis pilosula , 16 parts of Luo Han Guo, 16 parts of Moutan Cortex, 16 parts of White Horsetail, 16 parts of Cimicifuga, 20 parts of Miltonia, 20 parts of Ligustrum lucidum, 20 parts of Forsythia, 20 parts of Chonglou, 20 parts of Shijunzi, 20 parts of Artemisia annua 20 parts of motherwort, 22 parts of kudzu root, 22 parts of white peony, 22 parts of Chinese yam, 22 parts of white fresh skin, 22 parts of Andrographis paniculata, 22 parts of honeysuckle, 22 parts of hawthorn, 24 parts of cassia twig, 24 parts of ground walnut, 24 parts of Poria cocos , 24 parts of inverted root, 24 parts of Gentiana, 24 parts of black plum, 24 parts of schisandra, 24 parts of Chuanxiong, 26 parts of this...

Embodiment 3

[0029] A pharmaceutical composition for treating postoperative hypothermia in obstetrics and gynecology. The raw material composition and parts by weight of the pharmaceutical composition are: 6 parts of cloves, 6 parts of Shichangpu, 6 parts of black fungus, and 6 parts of Codonopsis pilosula , 10 parts of Luo Han Guo, 10 parts of Moutan Bark, 10 parts of White Horsetail, 10 parts of Cimicifuga, 13 parts of Miltonia, 13 parts of Ligustrum lucidum, 13 parts of Forsythia, 13 parts of Chonglou, 13 parts of Gentleman, 13 parts of Artemisia annua 13 parts of motherwort, 15 parts of kudzu root, 15 parts of white peony, 15 parts of Chinese yam, 15 parts of white fresh skin, 15 parts of Andrographis paniculata, 15 parts of honeysuckle, 15 parts of hawthorn, 17 parts of cassia twig, 17 parts of ground walnut, 17 parts of Poria cocos , 17 parts of inverted root, 17 parts of Gentiana, 17 parts of black plum, 17 parts of schisandra, 17 parts of Chuanxiong, 19 parts of thistle, 19 parts of...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine composition for treating gynecologic postoperative low fever. The medicine composition is prepared from the following medicinal raw materials: clove, rhizoma acori graminei, black fungus, codonopsis pilosula, momordica grosvenori, cortex moutan, cynanchum atratum, rhizoma cimicifugae, spatholobus suberctu, ligustrum lucidum ait, fructus forsythiae, rhizoma paridis, fructus quisqualis, abrotani herba, herba leonuri, kudzu vine roots, radix paeoniae alba, Chinese yam, cortex dictamni, common andrographis herb, lonicera japonica, haws, cassia twigs, viola collina bess, poria cocos, rubus coreanus, gentiana macrophylla, fructus mume, schisandra chinensis, ligusticum wallichii, herba cepbalanoplosis segeti, black soybeans, coked malt, oldenlandia diffusa, lily, licorice roots, mangnolia officinalis, Chinese dates, turtle shell, dahurian patrinia herb and fritillaria. The medicinal materials for preparing the medicine composition are interacted and synergized to treat both symptoms and root causes. The medicine composition can be used for effectively treating gynecologic postoperative low fever, greatly shortening recovery time of patients and effectively improving and optimizing the physical constitution and living quality of patients, and has an excellent treatment effect in clinical tests.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a pharmaceutical composition for treating postoperative hypothermia in obstetrics and gynecology. Background technique [0002] Postoperative hypothermia in obstetrics and gynecology is a very common clinical obstetrics and gynecology disease. Its clinical symptoms mainly include cough, palpitations, loss of appetite, fatigue, dizziness, etc. The main causes are inflammatory reactions such as tuberculosis and rheumatism, and long-term exposure to Huge pressure leads to damage to the body temperature nerve center, etc. Many reasons can lead to persistent low-grade fever, and the mood of the patient is also closely related to the onset of the disease. At present, Western medicine mostly adopts intravenous antibiotics, which is costly and has great side effects. In Western medicine and Chinese medicine, there is still a lack of drugs that can effectively treat postoperative hypoth...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8998A61K9/20A61K9/16A61K9/14A61K9/00A61P29/00A61P15/00A61K35/586
CPCA61K36/61A61K9/0095A61K9/14A61K9/1623A61K9/2059A61K35/586A61K36/07A61K36/076A61K36/185A61K36/19A61K36/236A61K36/27A61K36/28A61K36/282A61K36/344A61K36/355A61K36/42A61K36/48A61K36/484A61K36/486A61K36/488A61K36/51A61K36/533A61K36/54A61K36/57A61K36/575A61K36/634A61K36/638A61K36/65A61K36/71A61K36/725A61K36/73A61K36/734A61K36/736A61K36/748A61K36/75A61K36/79A61K36/86A61K36/888A61K36/8945A61K36/896A61K36/8966A61K36/8967A61K36/8998A61K47/26A61K2236/331A61K2236/39A61K2236/51A61K2236/53A61K2300/00
Inventor 杜娟
Owner 杜娟
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap